Is Bcr-Abl expression relevant for the survival of cancer stem cells in chronic myeloid leukaemia (CML)?

被引：0

作者：

Helgason, G. V. ^{[1
]}

Hamilton, A. ^{[1
]}

Myssina, S. ^{[2
]}

Jorgensen, H. G. ^{[1
]}

Bhatia, R. ^{[3
]}

Modi, H. ^{[3
]}

Schemionek, M. ^{[4
]}

Koschmieder, S. ^{[4
]}

Brunton, V.

Holyoake, T. L. ^{[1
,5
]}

机构：

[1] Univ Glasgow, Fac Med, Paul Ogorman Leukaemia Res Ctr, Sect Expt Haematol,Div Canc Sci & Mol Pathol, Glasgow, Lanark, Scotland

[2] Newcastle Univ, Sch Med, Newcastle Upon Tyne, Tyne & Wear, England

[3] City Hope Hosp, Dept Haematol, Duarte, CA USA

[4] Univ Munster, Dept Haematol & Med Oncol, D-4400 Munster, Germany

[5] Univ Edinburgh, Inst Genet & Mol Med, Div Canc Biol, Edinburgh, Midlothian, Scotland

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2010年 / 149卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

178

引用

页码：72 / 72

页数：1

共 50 条

[11] BCR-ABL peptide boost vaccinations can maintain anti-BCR-ABL immune responses in chronic myeloid leukaemia (CML) patients [J].

Rojas, J. M. ;

Knight, K. ;

Watmough, S. ;

Bell, J. ;

Wang, L. H. ;

Clark, R. E. .

BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 :63-63

[12] BCR-ABL insufficiency for the transformation of human stem cells into CML [J].

Matioli, GT .

MEDICAL HYPOTHESES, 2002, 59 (05) :588-589

[13] Detection of BCR-ABL transcripts in chronic myeloid leukaemia by nested PCR [J].

Otazú, IB ;

Zalcberg, I ;

Tabak, DG ;

Seuánez, HN .

LEUKEMIA RESEARCH, 1999, 23 (02) :185-190

[14] Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment [J].

Clapper, Erin ;

Wang, Sicong ;

Raninga, Prahlad V. ;

Di Trapani, Giovanna ;

Tonissen, Kathryn F. .

ANTIOXIDANTS, 2020, 9 (03)

[15] CCN3 expression is reduced as a result of Bcr-Abl kinase in chronic myeloid leukaemia [J].

不详 .

JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (05) :473-473

[16] Increase of BCR-ABL/ABL Ratio That Corresponds to BCR-ABL Mutation Detection In Chronic Myeloid Leukemia (CML) Patients Treated by Imatinib (IM) [J].

Tsaur, Grigory ;

Popov, Alexander ;

Ivanova, Anna ;

Yakovleva, Yulia ;

Riger, Tatyana ;

Plekhanova, Olga ;

Ivanets, Yulia ;

Shorikov, Egor ;

Saveliev, Leonid ;

Fechina, Larisa .

FASEB JOURNAL, 2011, 25

[17] EVALUATION OF BCR-ABL MONITORING IN CHRONIC MYELOID LEUKEMIA (CML) IN CLINICAL PRACTICE [J].

Romvari, Edie ;

Bollu, Vamsi ;

Morlock, Robert ;

Teitelbaum, April ;

Henk, Henry ;

Garcia, Reynaldo .

ONCOLOGY NURSING FORUM, 2011, 38 (02) :E160-E161

[18] Direct evidence that chronic myeloid leukaemia (CML) cells can express BCR-ABL junctional oligopeptides in association with class IHLA. [J].

Clark, RE ;

Hill, SC ;

Lill, JR ;

Norbury, LC ;

Christmas, SE ;

Bonner, PLR ;

Creaser, CS ;

Rees, RC .

BLOOD, 2000, 96 (11) :510A-511A

[19] Consequences of BCR-ABL expression within the hematopoietic stem cell in chronic myeloid leukemia [J].

Kabarowski, JHS ;

Witte, ON .

STEM CELLS, 2000, 18 (06) :399-408

[20] Are there better Bcr-Abl kinase inhibitors for chronic myeloid leukaemia than imatinib? [J].

Doggrell, Sheila A. ;

Christensen, Anne-Marie .

EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (01) :154-163

← 1 2 3 4 5 →